chr12-102958393-C-CGCAGCAGCAGCAGCA

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2

The NM_004316.4(ASCL1):​c.172_186dup​(p.Gln58_Gln62dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00070 ( 1 hom. )
Failed GnomAD Quality Control

Consequence

ASCL1
NM_004316.4 inframe_insertion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2B:1

Conservation

PhyloP100: 0.219
Variant links:
Genes affected
ASCL1 (HGNC:738): (achaete-scute family bHLH transcription factor 1) This gene encodes a member of the basic helix-loop-helix (BHLH) family of transcription factors. The protein activates transcription by binding to the E box (5'-CANNTG-3'). Dimerization with other BHLH proteins is required for efficient DNA binding. This protein plays a role in the neuronal commitment and differentiation and in the generation of olfactory and autonomic neurons. Mutations in this gene may contribute to the congenital central hypoventilation syndrome (CCHS) phenotype in rare cases. [provided by RefSeq, Jul 2008]
PAH (HGNC:8582): (phenylalanine hydroxylase) This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BS2
High AC in GnomAd4 at 151 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ASCL1NM_004316.4 linkuse as main transcriptc.172_186dup p.Gln58_Gln62dup inframe_insertion 1/2 ENST00000266744.4
PAHNM_001354304.2 linkuse as main transcriptc.-295_-294insTGCTGCTGCTGCTGC 5_prime_UTR_variant 1/14

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ASCL1ENST00000266744.4 linkuse as main transcriptc.172_186dup p.Gln58_Gln62dup inframe_insertion 1/21 NM_004316.4 P1
PAHENST00000547319.1 linkuse as main transcriptn.17_18insTGCTGCTGCTGCTGC non_coding_transcript_exon_variant 1/34
PAHENST00000551337.5 linkuse as main transcript upstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00101
AC:
151
AN:
150120
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00191
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000396
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.000394
Gnomad SAS
AF:
0.000629
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000876
Gnomad OTH
AF:
0.000975
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000702
AC:
952
AN:
1356658
Hom.:
1
Cov.:
17
AF XY:
0.000747
AC XY:
500
AN XY:
669094
show subpopulations
Gnomad4 AFR exome
AF:
0.00133
Gnomad4 AMR exome
AF:
0.00113
Gnomad4 ASJ exome
AF:
0.0000416
Gnomad4 EAS exome
AF:
0.000509
Gnomad4 SAS exome
AF:
0.000342
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000746
Gnomad4 OTH exome
AF:
0.000673
GnomAD4 genome
AF:
0.00101
AC:
151
AN:
150210
Hom.:
0
Cov.:
0
AF XY:
0.00102
AC XY:
75
AN XY:
73326
show subpopulations
Gnomad4 AFR
AF:
0.00190
Gnomad4 AMR
AF:
0.000396
Gnomad4 ASJ
AF:
0.000289
Gnomad4 EAS
AF:
0.000396
Gnomad4 SAS
AF:
0.000630
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000876
Gnomad4 OTH
AF:
0.000965

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineSep 25, 2014The Gln51[17] variant in ASCL1 (alternate gene names: MASH1 or HASH1) represents one of several alleles of a poly-glutamine tract of variable length. The Gln51[ 12] allele represents the reference sequence (hg19). This variant has been ident ified by our laboratory in one Caucasian individual with pulmonary fibrosis (LMM unpublished data). In addition, this variant has also been reported in 0.1% (1/ 1604) of Japanese control chromosomes (Ide 2005) and in 0.3% (1/304) of Caucasia n control chromosomes tested by our laboratory. Computational prediction tools a nd conservation analysis are limited or unavailable for this variant. In summary , the clinical significance of the Gln51[17] variant is uncertain. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
ASCL1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 09, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3832799; hg19: chr12-103352171; API